PT
Menu
Search
Sections
Home
News
Analysis
Features
Comment & Opinion
Projects
Data Insights
Sectors
Clinical Trials
Drug Manufacturers
Therapy Area
Cardiovascular
Central Nervous System
Immunology
Infectious Disease
Oncology
Respiratory
Pricing and Market Access
Themes
Artificial Intelligence
Corporate Governance
Cloud
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Insights
Deals
Jobs
Filings
Patents
Social Media
Companies
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Events
Reports
Premium Insights
Excellence Awards
Innovation Rankings
Magazine
Newsletters
GlobalData
About us
Advertise With Us
Contact Us
Our Marketing Solutions
GlobalData Reports
Visit GlobalData
From Our Partners
Optimizing Cell & Gene Therapy Processes
Collaboration and Expertise in Contract Analytical Chemistry
A new generation of CDMO services
Accelerating Biopharmaceutical Innovation
Precision medicine and digital health innovation for disease diagnosis, care and treatment
Enabling process intensification in biopharma manufacturing
The next chapter of clinical trial services
Putting quality first in the pharma supply chain
Pharmaceutical Grade Silicone Manufacturer
Maximising molecule potential
News
Analysis
Sections
Features
Comment & Opinion
Projects
Data Insights
Latest
Drug delivery innovations push forth women’s health
Harnessing pharmacovigilance to turn reactive investigation into active discovery
Continuous monitoring expands aseptic knowledge and data in real time
Sectors
Sections
Clinical Trials
Drug Manufacturers
Therapy Area
Pricing and Market Access
Latest
Chemomab touts study confirming CCL24 link to systemic sclerosis severity
OncoX inks licensing deal worth over $26m for NSCLC therapy
Theolytics secures funds to advance oncolytic adenovirus therapy
Themes
Sections
Artificial Intelligence
Cloud
Corporate Governance
Cybersecurity
Environmental Sustainability
Internet of Things
Robotics
Social Responsibility
Covid-19
Foreign Direct Investment
Latest
Ultimovacs downsizes to funnel funds to cancer vaccine programme
Johnson & Johnson reports net earnings of $5.3bn in Q1 2024
TetraScience and Google Cloud link for AI-driven drug developments
Insights
Sections
Deals
Jobs
Filings
Patents
Social Media
Latest
Johnson & Johnson reports net earnings of $5.3bn in Q1 2024
Merck reports drop in net income for fiscal 2023
Moderna reports net loss of $4.7bn for full year 2023
Companies
Sections
Company A-Z
Company Categories
Products & Services
Company Releases
White Papers
Videos
Buyer's Guides
Partner Content
Latest
Comprehensive clinical trial services
The importance of finding a versatile, scalable CDMO in the softgel market
Leading providers of washing, disinfection and sterilisation equipment and services
Events
Buy Reports
Newsletters
PT
Trial Termination
Galecto terminates development for its lead candidate
Palisade Bio terminates its post-surgical abdominal adhesions treatment trial
Sign up for our daily news round-up!
Give your business an edge with our leading industry insights.
Sign up
View more
